泰凌医药(新)股价重挫13.69% 市值跌1028.6万港元

自选股智能写手07-22

2024年07月22日早盘10时04分，泰凌医药(新)（01011.hk）股票出现波动，股价急速下挫13.69%。截至发稿，该股报0.290港元/股，成交量10万股，换手率0.04%，振幅1.49%。资金方面，该股资金流入0港元，流出2.935万港元。最近的财报数据显示，该股实现营业收入812.83万港元，净利润-1.58亿港元，每股收益-0.08港元，毛利数据暂无，市盈率-0.48倍。机构评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2453396786?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-07-22 10:04","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2453396786","market":"hk","top_or_hot":-1,"title":"泰凌医药(新)股价重挫13.69% 市值跌1028.6万港元","media":"自选股智能写手","content":"<div>\n<p>2024年07月22日早盘10时04分，泰凌医药(新)（01011.hk）股票出现波动，股价急速下挫13.69%。截至发稿，该股报0.290港元/股，成交量10万股，换手率0.04%，振幅1.49%。资金方面，该股资金流入0港元，流出2.935万港元。最近的财报数据显示，该股实现营业收入812.83万港元，净利润-1.58亿港元，每股收益-0.08港元，毛利数据暂无，市盈率-0.48倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722100431af9354a5&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>泰凌医药(新)股价重挫13.69% 市值跌1028.6万港元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n泰凌医药(新)股价重挫13.69% 市值跌1028.6万港元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-22 10:04 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722100431af9354a5&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>2024年07月22日早盘10时04分，泰凌医药(新)（01011.hk）股票出现波动，股价急速下挫13.69%。截至发稿，该股报0.290港元/股，成交量10万股，换手率0.04%，振幅1.49%。资金方面，该股资金流入0港元，流出2.935万港元。最近的财报数据显示，该股实现营业收入812.83万港元，净利润-1.58亿港元，每股收益-0.08港元，毛利数据暂无，市盈率-0.48倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722100431af9354a5&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1191","symbol_name":"制药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722100431af9354a5&s=b","article_id":"2453396786","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722100431af9354a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2453396786","pubTimestamp":1721613871,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"2024年07月22日早盘10时04分，泰凌医药(新)股票出现波动，股价急速下挫13.69%。截至发稿，该股报0.290港元/股，成交量10万股，换手率0.04%，振幅1.49%。资金方面，该股资金流入0港元，流出2.935万港元。泰凌医药(新)股票所在的药品行业中，整体涨幅为0.17%。其相关个股中，中生联合、康龙化成、泰凌医药(旧)涨幅较大，振幅较大的相关个股有中生联合、三爱健康集团、李氏大药厂，振幅分别为20.78%、6.25%、6.19%。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1191":"制药","01011":"泰凌医药(新)"},"translate_title":"NT Pharma (New) stock price plummeted 13.69%, market value fell by HK $10.286 million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01011":1},"content_text":"2024年07月22日早盘10时04分，泰凌医药(新)（01011.hk）股票出现波动，股价急速下挫13.69%。截至发稿，该股报0.290港元/股，成交量10万股，换手率0.04%，振幅1.49%。资金方面，该股资金流入0港元，流出2.935万港元。最近的财报数据显示，该股实现营业收入812.83万港元，净利润-1.58亿港元，每股收益-0.08港元，毛利数据暂无，市盈率-0.48倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。泰凌医药(新)股票所在的药品行业中，整体涨幅为0.17%。其相关个股中，中生联合、康龙化成、泰凌医药(旧)涨幅较大，振幅较大的相关个股有中生联合、三爱健康集团、李氏大药厂，振幅分别为20.78%、6.25%、6.19%。泰凌医药(新)公司简介：中国泰凌医药集团有限公司是一家主要从事医药产品研发、生产和销售的投资控股公司。该公司主要提供自有药品的开发、销售及代理商销售服务。该公司通过提供包括骨骼健康产品、设备和复健产品在内的客制化健康包来运营其骨健康数字医药平台。此外,该公司还从事药品和制药公司的股权投资以及向供应商提供行销和推广服务。消息层面，截至10时04分，《泰凌医药(01011)终止收购单克隆抗体商业化权利》资讯为影响泰凌医药(新)的重要信息。该信息摘要如下：泰凌医药(01011)公布，于2022年6月21日，被许可方Green-Life Technology(HongKong) Company Limited(公司全资附属公司)与许可方Abcentra LLC订立许可及合作协议，许可方有条件同意不可撤销地授予被许可方许可，即于中国内地、中国香港、中国澳门、中国台湾、新加坡、马来西亚及泰国等地区将该技术商业化的独家永久许可。由于被许可方与许可方无法就产品的延迟研发时间表的调整达成一致，被许可方与许可方同意终止收购事项。董事会认为终止收购事项不会对集团现有业务营运及财务状况产生重大不利影响。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2453396786"}